Overnight rostral fluid shift and obstructive sleep apnea in treatment resistant hypertension: Connecting the dots clarifies the picture

Hypertension

Volumn 56, Issue 6, 2010, Pages 1040-1041

  Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRONOLACTONE;

DISEASE SEVERITY; FLUID SHIFT; HUMAN; HYPERTENSION; NOTE; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ALDOSTERONE; BLOOD VOLUME; DRUG RESISTANCE; FLUID SHIFTS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; RENIN; SLEEP APNEA, OBSTRUCTIVE; SPIRONOLACTONE;

EID: 78650415306     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.161422     Document Type: Note

References (8)

1. Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension. 2010;56:1077-1082.
2. Balkau B, Vol S, Loko S, Andriamboavonjy T, Lantieri O, Gusto G, Meslier N, Racineux JL, Tichet J. High baseline insulin levels associated with 6-year incident observed sleep apnea. Diabetes Care. 2010;33: 1044-1049.
3. Goodfriend TL. Obesity, sleep apnea, aldosterone, and hypertension. Curr Hypertens Rep. 2008 10:222-226.
4. Isaksson H, Cederholm T, Jansson E, Nygren A, Ö stergren J. Therapy-resistant hypertension associated with central obesity, insulin resistance, and large muscle fiber area. Blood Pressure. 1993;2:46-52.
5. Modan M, Almog S, Fuchs Z, Chetrit, Lusky A, Halkin H. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension. 1991;17:565-573.
6. Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, Calhoun DA. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24:532-537.
7. Kapa S, Kuniyoshi FHS, Somers VK. Sleep apnea and hypertension: Interactions and implications for management. Hypertension. 2008;51: 605-608.
8. Williams D, Croal B, Furnace J, Ross S, Witte K, Webster M, Critchen W, Webster J. The prevalence of raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic. Blood Pressure. 2006;15:164-168.